Barclays’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Buy |
|
|||||
|
2025
Q1 | $5.39M | Sell |
|
|||||
|
2024
Q4 | $4.89M | Sell |
|
|||||
|
2024
Q3 | $5.71M | Buy |
|
|||||
|
2024
Q2 | $1.36M | Sell |
|
|||||
|
2024
Q1 | $1.79M | Sell |
|
|||||
|
2023
Q4 | $3.42M | Sell |
|
|||||
|
2023
Q3 | $2.95M | Sell |
|
|||||
|
2023
Q2 | $5.34M | Sell |
|
|||||
|
2023
Q1 | $13.4M | Buy |
|
|||||
|
2022
Q4 | $2.78M | Buy |
|
|||||
|
2022
Q3 | $1.82M | Buy |
|
|||||
|
2022
Q2 | $186K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Sell |
|
|||||
|
2021
Q4 | $4.12M | Buy |
|
|||||
|
2021
Q3 | $656K | Buy |
|
|||||
|
2021
Q2 | $333K | Sell |
|
|||||
|
2021
Q1 | $981K | Buy |
|
|||||
|
2020
Q4 | $214K | Sell |
|
|||||
|
2020
Q3 | $284K | Buy |
|
|||||
|
2020
Q2 | $222K | Buy |
|
|||||
|
2020
Q1 | $42K | Sell |
|
|||||
|
2019
Q4 | $130K | Buy |
|
|||||
|
2019
Q3 | $174K | Sell |
|
|||||
|
2019
Q2 | $302K | Sell |
|
|||||
|
2019
Q1 | $812K | Sell |
|
|||||
|
2018
Q4 | $462K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $164K | Buy |
|
|||||
|
2018
Q1 | $102K | Buy |
|
|||||
|
2017
Q4 | $171K | Buy |
|
|||||
|
2017
Q3 | $4K | Sell |
|
|||||
|
2017
Q2 | $5K | Sell |
|
|||||
|
2017
Q1 | $20K | Buy |
|
|||||
|
2016
Q4 | $5K | Buy |
|